Annual Retained Earnings
-$60.78 M
-$22.27 M-57.81%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual retained earnings is -$60.78 million, with the most recent change of -$22.27 million (-57.81%) on December 31, 2023.
- During the last 3 years, GANX annual retained earnings has fallen by -$53.75 million (-764.03%).
- GANX annual retained earnings is now -1658.18% below its all-time high of -$3.46 million, reached on December 31, 2019.
Performance
GANX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$77.43 M
-$4.49 M-6.15%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly retained earnings is -$77.43 million, with the most recent change of -$4.49 million (-6.15%) on September 30, 2024.
- Over the past year, GANX quarterly retained earnings has dropped by -$16.64 million (-27.38%).
- GANX quarterly retained earnings is now -1000.61% below its all-time high of -$7.03 million, reached on December 1, 2020.
Performance
GANX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GANX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.8% | -27.4% |
| 3 y3 years | -764.0% | -270.0% |
| 5 y5 years | - | -270.0% |
GANX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -190.5% | at low | -270.0% | at low |
| 5 y | 5-year | -1658.2% | at low | -1000.6% | at low |
| alltime | all time | -1658.2% | at low | -1000.6% | at low |
Gain Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$77.43 M(+6.1%) |
| Jun 2024 | - | -$72.94 M(+12.6%) |
| Mar 2024 | - | -$64.80 M(+6.6%) |
| Dec 2023 | -$60.78 M(+57.8%) | -$60.78 M(+8.4%) |
| Sep 2023 | - | -$56.06 M(+9.2%) |
| Jun 2023 | - | -$51.34 M(+17.6%) |
| Mar 2023 | - | -$43.65 M(+13.3%) |
| Dec 2022 | -$38.52 M | -$38.52 M(+13.8%) |
| Sep 2022 | - | -$33.84 M(+15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$29.28 M(+21.0%) |
| Mar 2022 | - | -$24.20 M(+15.6%) |
| Dec 2021 | -$20.93 M(+197.5%) | - |
| Dec 2021 | - | -$20.93 M(+18.2%) |
| Sep 2021 | - | -$17.71 M(+35.8%) |
| Jun 2021 | - | -$13.04 M(+37.5%) |
| Mar 2021 | - | -$9.49 M(+34.8%) |
| Dec 2020 | -$7.03 M(+103.5%) | - |
| Dec 2020 | - | -$7.03 M |
| Dec 2019 | -$3.46 M | - |
FAQ
- What is Gain Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Gain Therapeutics?
- What is Gain Therapeutics annual retained earnings year-on-year change?
- What is Gain Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Gain Therapeutics?
- What is Gain Therapeutics quarterly retained earnings year-on-year change?
What is Gain Therapeutics annual retained earnings?
The current annual retained earnings of GANX is -$60.78 M
What is the all time high annual retained earnings for Gain Therapeutics?
Gain Therapeutics all-time high annual retained earnings is -$3.46 M
What is Gain Therapeutics annual retained earnings year-on-year change?
Over the past year, GANX annual retained earnings has changed by -$22.27 M (-57.81%)
What is Gain Therapeutics quarterly retained earnings?
The current quarterly retained earnings of GANX is -$77.43 M
What is the all time high quarterly retained earnings for Gain Therapeutics?
Gain Therapeutics all-time high quarterly retained earnings is -$7.03 M
What is Gain Therapeutics quarterly retained earnings year-on-year change?
Over the past year, GANX quarterly retained earnings has changed by -$16.64 M (-27.38%)